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Abstract 
Instrument assisted soft tissue mobilization or IASTM/ASTM is a relatively new treatment for 
the treatment of musculoskeletal conditions. This critical review sought to identify if IASTM can 
decrease pain and recovery time in subjects with musculoskeletal injuries compared to traditional 
treatment protocol. A database search was done to find studies that looked at the use of IASTM 
for treatment of musculoskeletal conditions. The selected study was Augmented Soft Tissue 
Mobilization vs Natural History in the Treatment of Lateral Epicondylitis: A Pilot Study 
Blanchette et al. In this study, the researchers compared education on LE as a control to an 
ASTM group. They found significant differences in the pain measurements in the ASTM group. 
However, there was one clinician that provided all treatments and data collection which allowed 
for potential bias to influence the results. As well, there was a significant difference between the 
time since onset of symptoms in the two groups, which could have affected the potential 
improvement in the control group. Because of the potential bias and initial difference, this study 
should not be used as a stand-alone reason to perform ASTM on a patient, but serves as a starting 
point for a follow up study with a stronger design to prevent potential bias.  
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Introduction 
Instrument assisted soft tissue mobilization (IASTM or ASTM) is a developing treatment in the 
field of physical therapy. It involves the use of tools to assist therapists in manual therapy 
techniques. However, its effect has not been completely identified. One potential use of that can 
be further investigated IASTM is the treatment of musculoskeletal injuries. The clinical question 
I sought to answer was: Does IASTM decrease pain and recovery time in subjects with 




I conducted a database search using Academic Search Complete, CINAHL, MEDLINE, 
Rehabilitation & Sports Medicine Source, SPORTDiscus. These were all chosen to give a large 
breadth of available articles as well as those with greater emphasis on physical therapy and 
sports rehabilitation. I limited the search to: full text, peer reviewed articles only, within the last 
15 years, experimental design, and English language only. I did this because I wanted to find 
more recent evidence in this area that provided an experimental design against exercise only 
groups. Because of the broad definition of IASTM and the different techniques that it involves, I 
included those articles that used IASTM, Graston, Gua sha, and Fascial Abrasion Technique. 
Also, because of the nature of the assignment, I excluded systematic reviews and meta-analyses. 
I was anticipating around 100 articles, and after I applied my criteria the search came up with 89 
articles that fit. I narrowed it down to three articles based on what was the closest fit to my 
clinical question in the experimental design. This broadened my question from just muscular 
injuries, to a more broad musculoskeletal injuries.  
The study that best fit the above clinical question was: Augmented Soft Tissue Mobilization vs 
Natural History in the Treatment of Lateral Epicondylitis: A Pilot Study by Marc-André 
Blanchette, DC, MSc, and Martin C. Normand, DC, PhD. This study was done to investigate the 
effects of treatment of lateral epicondylitis (LE) with Augmented Soft Tissue Mobilization 
(ASTM) because this is the most common diagnosis of the elbow which is linked to absenteeism 
from work and residual disabilities after diagnosis. I chose this article because it fit most closely 
to my clinical question in the experimental design. This study has some deficits to be addressed. 
All of the treatments, and data collection were done by a single clinician which opens the door 
for potential bias in the results. As well, the control group had a significantly longer duration of 
the condition prior to the study, which could mean that the control group had a lower potential 
for improvement in their symptoms although their outcome measures were similar at the 




Summary of the study 
The researchers took 30 subjects and randomly allocated to the ASTM group where the subjects 
received ASTM treatments 2 times per week for 5 weeks or the control group where the subjects 
were educated on the natural progression of LE, advice on workstation ergonomics, and 
stretching exercises to do 30 seconds, 6 times per day.  Disease progress was measured using the 
Patient-Rated Tennis Elbow Evaluation (PRTEE), the Visual Analog Scale (VAS), and Pain Free 
Grip Strength (PGS) both before the treatment began, after 6 weeks, and a long term follow up at 
3 months. However, all of the subjects were treated by and had the data collected by a single 
researcher. Only the ASTM group saw significant improvements in both the PRTEE and VAS 
scores at the 6 week follow up, and all of the subjects saw significant improvements in PFG at 6 
weeks and all measures at 3 months. The researchers admit that the population of this study is 
not indicative of all LE patient nor did they identify the predisposing factors in the subjects’ 
diagnosis. Because of this, they could not conclude a treatment suggestion in this study, but 
outlined a larger follow-up study, and recommended small tweaks in the study design to 
minimize potential bias in the results. 
 
Appraisal of the study introduction 
Overall, it was it was written well. The authors showed how debilitating lateral epicondylitis can 
be for patients. The aims of this study are to identify if ASTM could be used to treat LE. The authors 
identify literature to support their hypothesis. The critical variables have all been addressed in the 
introduction the independent variables were ASTM and education control. The dependent variables were 
the VAS, PFG, and PRTEE. It was clear and well written.  
I would like to know the method of how the IASTM was performed. Some of the journal articles 
were from the 70s, so they are not very current, and it is likely that the data in those studies could be 
outdated. I feel like they should have provided more information on their reasoning to use ASTM as a 
treatment.  
Appraisal of the study methods 
This study was a longitudinal experimental design. 35 subjects were recruited, 30 
participated in the study. 3 dropped out from the control group. It is possible those subjects were 
not improving and they did not feel motivated to show up. The subjects were split into 2 groups 
and results were compared between subjects. It did not say specifically if the subjects were 
blinded. The Control group had a significantly longer time since onset of the disease. The 
investigators managed all of the groups the same except for the experimental intervention. The 
outcome measures were supported in sufficient detail. The procedure of data collection was 
explained clearly and could be replicated by others looking to replicate the study. They analyzed 
the data using ANOVA and SPSS. 
One limitation in their design is that they did not say the exact method of the ASTM 
applied to the subjects, therefore it cannot be exactly replicated A single clinician collected all of 
the data and applied all of the treatments.. As well, they did not speak much of the validity of the 
tools, though they did touch on it.  
 
Appraisal of the study results 
Overall, it was well organized and clear in the order that it was presented. They addressed all of 
the aims measured and reported all of the outcome measures presented in the methods. The p value they 
used was .05 and the confidence interval was 95%. The statistically significant results they found were: 
PRTEE and VAS at 6 weeks for the ASTM and 3 months for both groups and, PFG for both at 6 weeks.  
However, they only described their results to a minimal extent which is why I think a bar graph 
comparing the results would have presented the information better than only using the tables as the 
researchers did. All of the figures were presented well and clearly, but it would have been nice to see a 
line graph to compare change over time. They did not identify a minimally clinically important 




Appraisal of the study discussion 
They expanded more on the meaning of their findings in the end of their discussion, and 
they tied the findings into existing literature effectively. They also outlined a follow up study 
with more participants and a blind put in place to reduce potential bias and to find a clinically 
significant result.  
Some of the journals they cited were more than 20 years old, so it is possible that the data 
in those is no longer applicable. They listed a couple of limitations to their study, those are: a 
significant difference in onset of conditions there was a low number of participants, and there 
was no blind for the researcher.  
Discussion 
 This study mildly supports the idea for using IASTM or ASTM for treatment of 
musculoskeletal conditions for a more rapid recovery. Because of the potential bias in this study 
and the difference in time since onset of symptoms between the two groups, this study alone 
cannot justify the use of IASTM in a clinical setting. This study specifically supported a more 
rapid recovery in lateral epicondylitis, which is an inflammation of the common extensor tendon 
of the forearm. However, this study needs to be re-visited with a larger subject population and in 
a way that minimizes potential bias.  
 From the results of this study, I would argue in favor of using ASTM for treatment of LE. 
There are potential benefits and risks of using this treatment, the data presented in this study 
shows that there can be a significant improvement in symptoms with the use of ASTM. The side 
effects of this treatment are common, but mild. Those include redness and irritation as well as 
soreness in the area. Redoing this study with a separate researcher collecting the data that was 
blind to the subject condition, and without a significant initial difference in subjects’ symptoms 
would improve the argument in favor of using ASTM. 
  This paper alone is not enough to justify the use of ASTM with patients or clients, but it 
does add to the body of evidence in support of the use. However, I would feel comfortable using 
this treatment with a patient with LE because I have been certified in IASTM. In order to apply 
this treatment to a broader patient population, I would want more experience to improve my skill 
level in this treatment. 
 Blanchette et al. designed this as a pilot study to investigate the use of ASTM in the 
treatment of LE. In that aim, I think they accomplished their goal, but this study needs to be 
revisited with a different design, as they suggest. Their results do support the further 
investigation in this treatment, but have a potential for bias because there was only one clinician 
that was not blinded in the treatment condition during data collection.  
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